Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RETRO: Reduction of Therapy in RA
NCT02779114Phase 3Unknown
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Jan 2009
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in rheumatoid arthritis (RA) (3 arms), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Primary endpoint: Proportion of subjects in remission (DAS 28 < 2.6) at 12 months. Status: unknown.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02779114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02779114.